**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 1835-49-0 |Tetrafluoroterephthalonitrile | 97 | 217-397-3 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.The toxicological
properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin. May be
metabolized to cyanide which in turn acts by inhibiting cytochrome
oxidase impairing cellular respiration.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
May cause cardiac disturbances. The toxicological properties of this
substance have not been fully investigated. May cause central
nervous system depression. Metabolism may release cyanide, which may
result in headache, dizziness, weakness, collapse, unconsciousness
and possible death.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation. The
toxicological properties of this substance have not been fully
investigated. May cause cardiac abnormalities. May be metabolized to
cyanide which in turns act by inhibiting cytochrome oxidase impairing
cellular respiration. Inhalation at high concentrations may cause CNS
depression and asphixiation.
Chronic:
May be metabolized to cyanide which in turn acts by inhibiting
cytochrome oxidase impairing cellular respiration. Chronic exposure
to cyanide solutions may lead to the development of a "cyanide" rash,
characterized by itching, and by macular, papular, and vesicular
eruptions, and may be accompanied by secondary infections.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
May be partially metabolized to cyanide in the body.
Antidote:
Always have a cyanide antidote kit on hand when working with cyanide
compounds. Get medical advice to use.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Containers
may explode in the heat of a fire. Runoff from fire control or
dilution water may cause pollution.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use agent most
appropriate to extinguish fire. For small fires, use dry chemical,
carbon dioxide, or water spray. For large fires, use dry chemical,
carbon dioxide, alcohol-resistant foam, or water spray.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 1835-49-0:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: yellow to yellow-green
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 195 - 200 deg C
Autoignition Temperature: Not available.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8F4N2
Molecular Weight: 200.09
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 1835-49-0: CZ1955000
LD50/LC50:
CAS# 1835-49-0: Oral, mouse: LD50 = 56 mg/kg.
Carcinogenicity:
Tetrafluoroterephthalonitrile -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 1835-49-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 1835-49-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1835-49-0 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/04/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
6-Aminonicotinic Acid, 98%
| 3167-49-5 |
|
Rhodamine 6g Perchlorate, Laser Grade, 99% (TLC)
| 13161-28-9 |
|
3-Thiophenemalonic acid, 98+%
| 21080-92-2 |
|
Poly(Sodium-P-Styrenesulfonate), Average M.W.100.000
| 25704-18-1 |
|
3-Cyclohexylpropionaldehyde, 99%
| 4361-28-8 |
|
Tripropylamine, 99+%
| 102-69-2 |
|
1,10-Decanediol, 95% (GC)
| 112-47-0 |
|
Cyclooctanol, 99%
| 696-71-9 |
|
l-(-)-Sorbose, 99%
| 87-79-6 |
|
6-Bromo-2-Naphthyl-Beta-D-Glucopyranoside
| 15548-61-5 |
|
1-Hexadecylsulfonic acid, sodium salt, HPLC grade
| 15015-81-3 |
|
3-Carbethoxy-4-Piperidone Hydrochloride 98% (TLC)
| 4644-61-5 |
|
1,3-Dimethylurea, 98%
| 96-31-1 |
|
Diethyl 1,4-Dihydro-2,4,6-Trimethyl- 3,5-Pyridinedicarboxylate, 99%
| 632-93-9 |
|
Dimethylthiocarbamoyl Chloride, 99% (Titr.)
| 16420-13-6 |
|
3,3',5,5'-Tetramethylbenzidine, 99+%
| 54827-17-7 |
|
3,5-Diamino-1,2,4-Triazole 98%
| 1455-77-2 |
|
2-(Trifluoromethyl)benzimidazole
| 312-73-2 |
|
(1R,2R)-(+)-1,2-Diphenyl-1,2-Ethane Diamine, 99% (99% e.e.)
| 29841-69-8 |
|
1-Methyl-7-Hydroxy-6-Methoxy-3,4-Dihydroisoquinoline, 99+%
| 4602-70-4 |
|
Amberlite IRC-50 Ion-Exchange Resin
| 9002-29-3 |
|
Tetrahexylammonium Iodide, 99% (Titr.)
| 2138-24-1 |
|
L(-)-methanesulfonylethyllactate
| 63696-99-1 |
|
Tetrafluoroterephthalonitrile, 97%
| 1835-49-0 |
|
2-Furoic acid hydrazide, 98%
| 3326-71-4 |
|
4-Cyclohexylaniline, 97%
| 6373-50-8 |
|
8-Formyl-7-methoxy-1,4-dioxa-8-azaspiro[4.5]decane, tech., 85%
| |
|
(2-Hydroxybenzoyl)methylenetriphenylphosphorane, 98%
| 0-01-1 |
|
3-Acetyl-1-propanol, 96%
| 1071-73-4 |
|
4-Chlorobenzotrifluoride, 98%
| 98-56-6 |
|
p-Tolyl Isothiocyanate, 99%
| 622-59-3 |
|
Boron trifluoride - acetic acid complex, c a. 33% bf3
| 373-61-5 |
|
Titanium (IV) Oxide, 98.0 - 100.5% TiO2
| 13463-40-6 |
|
Ethylmercurithiosalicylic acid, sodium salt
| 54-64-8 |
|
1-Iodopentane, 97% (GC)
| 628-17-1 |
|
(4-Carboxybutyl)triphenylphosphonium bromide, 98%
| 17814-85-6 |
|
Dichloroacetyl Chloride, 97%
| 79-36-7 |
|
trans-Traumatic acid, 97%
| 6402-36-4 |
|
1,4-Pentadiene, 99%
| 591-93-5 |
|
2-Chloro-p-phenylenediamine dihydrochloride, 99% (uv-vis)
| 615-46-3 |
|
Calcium 2-ethylhexanoate
| 136-51-6 |
|
N-Hydroxysuccinimide, 98+%
| 6066-82-6 |
|
2,2-Diphenylpropylamine Hydrochloride, 95%
| 40691-66-5 |
|
Cerium atomic absorption standard solution 1 mg/ml Ce in 2% HNO3
| 7440-45-1 |
|
alpha-Pyridoin, 99%
| 1141-06-6 |
|
4,6-Dimethyl-2-Pyrone, 98%
| 675-09-2 |
|
Oleic acid, sodium salt, 65-90% oleic C18
| 143-19-1 |
|
(+/-)-Tetrahydropapaveroline Hydrobromide, 98%
| 4747-99-3 |
|
5-Bromo-2-fluorotoluene, 99%
| 51437-00-4 |
|
2-Methoxy-4-Methylphenol, 99% (GC)
| 93-51-6 |
|
|